Angelalign Technology Inc. (HKG:6699)
Hong Kong
· Delayed Price · Currency is HKD 56.00
+0.50 (0.90%)
Jun 6, 2025, 4:08 PM HKT
Angelalign Technology Revenue
In the year 2024, Angelalign Technology had annual revenue of $268.79M USD with 28.23% growth. Angelalign Technology had revenue of $75.38M in the quarter ending December 31, 2024, with 22.87% growth.
Revenue
$268.79M
Revenue Growth
+28.23%
P/S Ratio
4.56
Revenue / Employee
$75.16K
Employees
3,576
Market Cap
9.52B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |